PALO ALTO, Calif.--(BUSINESS WIRE)--Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, today announced that it will present at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14th, in San Francisco. Edward Kerslake, Chief Executive Officer of Topera, will address the conference at 3:30 p.m. Pacific Standard Time (PST).
About Topera, Inc.
Topera, Inc., a venture-backed medical device company, has developed a novel 3D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. The Topera 3D Mapping System, which consists of the RhythmViewTM Workstation and the FIRMapTM diagnostic catheter, is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia. For additional information, visit www.toperamedical.com.